Biodextris

Join Our Team

Current Job Offerings


 Project Manager 

 Manage biologics/vaccine projects by leading cross-functional teams, ensuring compliance with GMP standards, meeting client deliverables, optimizing resources, and maintaining budgets, timelines, and quality. PMP or Scrum Master certification preferred.

View Details

Quality Control Analysts

The QC Analyst executes analytical procedures and ensures compliance with predefined assay acceptance criteria and product specification. 

View Details

Bioprocess Scientist

The Scientist will be responsible for the independent design, planning, execution and technical transfer of complete bioprocesses for non-GMP or GMP projects, depending on specific project scope and client requirements. 

View Details

Recent Articles

Tips, News and Updates

By Philippe Beland June 11, 2025
Biodextris Appoints Dr. Behzad Mahdavi as Executive Chairman & Chief Commercial Officer Who: Dr. Behzad Mahdavi, Ph.D., MBA, NACD.DC — a biopharma industry veteran with over 25 years of senior leadership experience in CDMO and CRO sectors, including roles at Lonza and Catalent. What: He has been appointed Executive Chairman and will additionally serve as Chief Commercial Officer at Biodextris. Why: Dr. Mahdavi will spearhead the company’s global commercial expansion, leveraging his expertise in commercial innovation and international market development About Biodextris: Headquartered in Laval (Montréal), Québec, Biodextris is a rising Contract Development & Manufacturing Organization (CDMO) specializing in biologics and vaccine development, rooted in the legacy of GSK’s biologics and supported by ArchiMed private equity. For full details, you can read the original PR Newswire article here: https://www.prnewswire.com/news-releases/biodextris-appoints-dr-behzad-mahdavi-as-executive-chairman-to-lead-global-commercial-expansion-302472664.html
December 17, 2024
Learn about the strategic partnership between Aramis Biotechnologies and Biodextris to advance vaccine and biologics development.
December 17, 2024
Clean Biologics acquires Biodextris—bringing together expertise in biologics manufacturing and accelerating growth in CDMO services.